- Lobbying
- Lobbying by Association of Accessible Medicines
Lobbying Relationship
Bills mentioned
S.974: Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Sponsor: Patrick J. Leahy (D-Vt.)
H.R.2212: CREATES Act of 2017
Sponsor: Tom Marino (R-Pa.)
S.1948: A bill to abrogate the sovereign immunity of Indian tribes as a defense...
Sponsor: Claire McCaskill (D-Mo.)
S.1428: Preserve Access to Affordable Generics and Biosimilars Act
Sponsor: Amy Klobuchar (D-Minn.)
S.2891: Restoring the America Invents Act
Sponsor: Patrick J. Leahy (D-Vt.)
S.4417: Patent Trial and Appeal Board Reform Act of 2022
Sponsor: Patrick J. Leahy (D-Vt.)
S.2220: PREVAIL Act
Sponsor: Christopher A. Coons (D-Del.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Steven Duffield | Chief Counsel/Policy Director, Senate Republican Conference; Chief Counsel, Senate Republican Policy Committee; Judiciary Policy Analyst/Counsel, Senate Republican Policy Committee Chief counsel/Deputy Staff Director, Senate Republican Conference; Chief counsel/Deputy staff director, Senate Republican Policy Committee; Judiciary analyst/counsel, Senate Republican Policy Committee Senate Republican Conference, Chief Counsel, Policy Director; Senate Republican Policy Committee: Chief Counsel, Policy Analyst, Deputy Staff Director Senate Republican Conference (Policy Director); Senate Republican Policy Committee (Deputy Staff Director; Chief Counsel; Judiciary Policy Analyst) |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Federal Trade Commission (FTC)
U.S. House of Representatives
Health Issues
U.S. House of Representatives
Federal Trade Commission (FTC)
Health Issues
U.S. House of Representatives
Federal Trade Commission (FTC)
Health Issues
U.S. House of Representatives
Federal Trade Commission (FTC)
Health Issues
U.S. House of Representatives
Patent & Trademark Office (PTO)
Federal Trade Commission (FTC)
U.S. House of Representatives
U.S. House of Representatives
Patent & Trademark Office (PTO)
Federal Trade Commission (FTC)
U.S. House of Representatives
U.S. House of Representatives
Patent & Trademark Office (PTO)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate